Physician profile
Erickson Torio
NPI 1619549029
$11,485.82
in general payments reported to CMS, 2019-2025
7 companies · $7,988 in 2025
The $7,988 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,498 · 2025: $7,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,442 · Food and Beverage: $3,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,441.72 |
| Food and Beverage | $3,044.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,335.19 | 2025 | Penumbra System, Indigo System |
| Stryker Corporation | $2,849.06 | 2024-2025 | Core, Neuroform Ez 3, Target |
| Medtronic, INC. | $2,353.56 | 2024-2025 | Pipeline, Onyx 18, Axium Primetm |
| Microvention, INC. | $1,667.61 | 2025 | Web Aneurysm Embolization System, Sofia 6f-131cm Str |
| Medical Device Business Services, INC. | $1,028.18 | 2025 | Trufill |
| Imperative Care, INC | $161.57 | 2024 | Zoom 88-T Large Distal Platform |
| Amgen INC. | $90.65 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erickson Torio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.